2019
DOI: 10.1053/j.gastro.2019.06.001
|View full text |Cite
|
Sign up to set email alerts
|

Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

14
67
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
3
2

Relationship

2
7

Authors

Journals

citations
Cited by 92 publications
(83 citation statements)
references
References 42 publications
14
67
1
Order By: Relevance
“…We showed that the organoid culture model can recapitulate the morphological and mutational profiles of resected IPMNs, consistent with existing data on primary PDAC tumors [18][19][20][21] and a recently published manuscript on IPMNs 23 . Discordance of somatic mutations was reported in several parental tumor-PDO pairs, suggesting a different subclone of parental tissue may have been sequenced compared to the subclone(s) that grew into organoid culture, consistent with prior studies which reveal driver gene heterogeneity in IPMNs 23,40 .…”
Section: Discussionsupporting
confidence: 85%
See 1 more Smart Citation
“…We showed that the organoid culture model can recapitulate the morphological and mutational profiles of resected IPMNs, consistent with existing data on primary PDAC tumors [18][19][20][21] and a recently published manuscript on IPMNs 23 . Discordance of somatic mutations was reported in several parental tumor-PDO pairs, suggesting a different subclone of parental tissue may have been sequenced compared to the subclone(s) that grew into organoid culture, consistent with prior studies which reveal driver gene heterogeneity in IPMNs 23,40 .…”
Section: Discussionsupporting
confidence: 85%
“…DNA fingerprinting. To assess sample quality and integrity and establish sample identity, [34][35][36][37][38][39][40][41][42] ng (15 ng/µL) of isolated DNA from each sample was aliquoted and used to generate a DNA fingerprint with the 96-SNP Advanta™ SampleID Genotyping Panel (Fluidigm, Inc). Briefly, the DNA samples were pre-amplified using the Advanta specific target amplification (STA) primers according to the manufacturer's protocol and the amplified DNA along with the Advanta SampleID allele-specific (ASP) and locus-specific (LSP) primers were transferred to a Fluidigm 96.96 Dynamic Array Integrated Fluidics Circuit (IFC) for Genotyping.…”
Section: Imaging and Digital Quantification Of Patient-derived Organoidmentioning
confidence: 99%
“…Finally, while second primary carcinomas of the pancreas have been reported, our finding of a metachronous primary PDA in one of 10 otherwise unselected patients with an intrapancreatic mass post resection suggest that this phenomenon may be more common than previously appreciated (44,45). Detailed and formal prospective studies of intrapancreatic masses in patients who have undergone prior resection for PDA will be required to more firmly understand the frequency of second primary tumors and the risk factors associated with their development as has been shown for invasive carcinomas arising in intraductal papillary mucinous neoplasms of the pancreas (46).…”
Section: Discussionmentioning
confidence: 75%
“…Progress towards identifying those MCLs that harbor high-grade dysplasia or early invasive PDAC has been made. There is increasing knowledge about the progression of IPMNs from a genetic perspective which suggests that early lesions are heterogeneous, while those with high-grade dysplasia have a smaller number of homogeneous driver genes 42 . Preliminary studies evaluating the presence of mutations in PIK3CA, SMAD4 and TP53 in cyst fluid are promising, identifying almost 80% of IPMNs with high-grade dysplasia or cancer 43 .…”
Section: Cystic Lesionsmentioning
confidence: 99%